SCHEMBL4370150

SCHEMBL4370150

Cc1cccc(Cl)c1C(=O)NN

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 1/20 0.58
UTS2R Q9UKP6 1/20 0.49
ITGB1 P05556 3/20 0.48
ITGA4 P13612 3/20 0.48
ITGB7 P26010 2/20 0.48
ITGA2 P17301 1/20 0.48
GAA P10253 2/20 0.47
ALDH2 P05091 1/20 0.46
ALDH1A1 P00352 3/20 0.45
HPGD P15428 1/20 0.45
FEN1 P39748 1/20 0.44
ITGB2 P05107 1/20 0.44
ICAM1 P05362 1/20 0.44
ITGAL P20701 1/20 0.44
OGG1 O15527 1/20 0.44
P2RX7 Q99572 1/20 0.43
KMT2A Q03164 1/20 0.43
FABP3 P05413 1/20 0.43
FABP4 P15090 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19344748 0.86 P2RX7 (0.50) TYK2GAAALDH2ALDH1A1ITGB2
SCHEMBL4377125 0.86 ALDH1A1 (0.56) TYK2GAAALDH1A1HPGDFEN1
SCHEMBL13479838 0.80 TYK2 (0.52) TYK2UTS2RITGB1ITGA4ITGB7
SCHEMBL24209849 0.79 JAK1 (0.59) TYK2ALDH1A1HPGDFEN1OGG1
SCHEMBL10557796 0.79 P2RX7 (0.51) GAAALDH1A1HPGDFEN1P2RX7
SCHEMBL12473715 0.79 ALDH1A1 (0.47) TYK2ALDH1A1HPGDFEN1OGG1
SCHEMBL10558954 0.79 ALDH1A1 (0.50) ALDH1A1HPGDFEN1OGG1P2RX7
SCHEMBL14726669 0.79 TYK2 (0.55) TYK2UTS2RITGB1ITGA4ITGB7
SCHEMBL4919855 0.79 TYK2 (0.55) TYK2UTS2RITGB1ITGA4ITGB7
SCHEMBL1397518 0.79 TSHR (0.51) TYK2UTS2RGAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009109991-A2 NOVEL HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD., (IN) 2009-09-11 WO claimed
US-20240066014-A1 TREATMENT FOR PARKINSON'S DISEASE SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2024-02-29 US disclosed
WO-2022086284-A1 PROTEIN KINASE INHIBITOR AND USE THEREOF (주)메디톡스 2022-04-28 WO disclosed
EP-3297991-B1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RES CO LTD (IN) 2020-01-29 EP disclosed
EP-3297991-B1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RES CO LTD (IN) 2020-01-29 EP disclosed
US-10150733-B2 Amidoheteroaryl aroyl hydrazide ethynes SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2018-12-11 US disclosed
US-20180127372-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2018-05-10 US disclosed
US-20180127372-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2018-05-10 US disclosed
US-20180127372-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2018-05-10 US disclosed
EP-3297991-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES Sun Pharma Advanced Research Company Ltd (IN) 2018-03-28 EP disclosed
EP-2665709-B1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS SUN PHARMA ADVANCED RES CO LTD (IN) 2016-12-07 EP disclosed
WO-2016185490-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2016-11-24 WO disclosed
WO-2016185490-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2016-11-24 WO disclosed
US-9024021-B2 Diarylacetylene hydrazide containing tyrosine kinase inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2015-05-05 US disclosed
US-9024021-B2 Diarylacetylene hydrazide containing tyrosine kinase inhibitors SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2015-05-05 US disclosed
EP-2665709-A1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS Sun Pharma Advanced Research Company Limited (IN) 2013-11-27 EP disclosed
US-20130296557-A1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2013-11-07 US disclosed
US-20130296557-A1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD. (IN) 2013-11-07 US disclosed
WO-2012098416-A1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2012-07-26 WO disclosed
WO-2012098416-A1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2012-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066014-A1 TREATMENT FOR PARKINSON'S DISEASE SNCA, PARK7, AOC3 TYK2 4617/4885UTS2R 2749/4885ITGB1 3120/4885
US-20180127372-A1 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES ERBB2, ABL1, ERBB3 TYK2 67/4885UTS2R 1095/4885ITGB1 4080/4885
US-10150733-B2 Amidoheteroaryl aroyl hydrazide ethynes ERBB2, ABL1, ERBB3 TYK2 78/4885UTS2R 1174/4885ITGB1 4200/4885
US-20130296557-A1 DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS ABL1, LCK, JAK2 TYK2 110/4885UTS2R 1737/4885ITGB1 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.